Barlow Carrolee 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-02-23+6,293→ 6,293 totalExercise: $38.60Exp: 2033-02-23→ Common Stock (6,293 underlying) - Award
Restricted Stock Units
2023-02-23+3,886→ 3,886 total→ Common Stock (3,886 underlying)
Holdings
- 13,315
Common Stock
Footnotes (3)
- [F1]The option vests on February 23, 2024.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024.